Capricor Therapeutics reported $-7818000 in Net Income for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Bioline Rx BLRX:US $ -4.93M 0.63M
Capricor Therapeutics CAPR:US $ -7.82M 1.63M
Cytokinetics CYTK:US $ -89.44M 58.88M
Cytori Therapeutics CYTX:US $ -4.12M 0.04M
Geron GERN:US $ -30.1M 1.92M
Johnson & Johnson JNJ:US $ 5149M 413M
Newlink Genetics NLNK:US $ -7.72M 2.08M
Prothena PRTA:US $ -36.29M 3.11M
Ptc Therapeutics PTCT:US $ -126.73M 16.54M
Sarepta Therapeutics SRPT:US $ -105.02M 16.96M
Vascular Biogenics VBLT:US -10428000 1.32M
Vital Therapies VTL:US $ -20.81M 0.38M